Financhill
Back

Soleno Therapeutics Quote, Financials, Valuation and Earnings

Sell
43

SLNO
Soleno Therapeutics

Last Price:
41.09
Seasonality Move:
-12.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Soleno Therapeutics Price Quote

$41.09
-0.06 (0.83%)
(Updated: June 22, 2024 at 5:46 AM ET)

Soleno Therapeutics Key Stats

Sell
43
Soleno Therapeutics (SLNO) is a Sell

Day range:
$39.73 - $41.78
52-week range:
$3.69 - $53.82
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,179.82
P/B ratio:
10.58%

Volume:
1.5M
Avg. volume:
416.8K
1-year change:
734.69%
Market cap:
$1.5B
Revenue:
$0
EPS:
$-2.71

How Much Does Soleno Therapeutics Make?

Data Unavailable

Is Soleno Therapeutics Growing As A Company?

Data Unavailable

Soleno Therapeutics Stock Price Performance

What Is Soleno Therapeutics 52-Week High & Low?

Soleno Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Soleno Therapeutics?

Is Soleno Therapeutics Cash Flow Positive?

  • What Is SLNO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30.7M
  • What Is Soleno Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $181M
  • What Is Soleno Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$115.2M

Soleno Therapeutics Return On Invested Capital

Data Unavailable

Soleno Therapeutics Earnings Date & Stock Price

Soleno Therapeutics Competitors

Soleno Therapeutics Dividend Yield

Data Unavailable

Soleno Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 67.29
Upside from Last Price: 63.51%

Major Shareholders

  • How many SLNO shares are owned by institutional investors?
    51.1M SLNO shares are owned by institutional investors
  • How many SLNO shares are owned by insiders?
    912.4K SLNO shares are owned by insiders